Paper6413409
Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.
Ameglio F and 3 others. Infect Immun, 1983. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci. Papers, record 6413409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6413409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differential effects of gamma interferon on expression of HLA class II molecules controlled by the DR and DC loci.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation | Major topic |
| Genes, MHC Class II | Major topic |
| Histocompatibility Antigens Class II | Major topic |
| Interferon-gamma | Major topic |
| Cell Line | |
| HLA Antigens | |
| HLA-DQ Antigens | |
| HLA-DR Antigens | |
| HLA-DR4 Antigen | |
| HLA-DR6 Antigen | |
| Humans | |
| Melanoma |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 82605 | Immunological dissection of human Ia molecules. | J Exp Med | 1978 | https://conductscience.org/library/papers/82605 | PubMed |
| 2 | 83651 | Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. | Proc Natl Acad Sci U S A | 1978 | https://conductscience.org/library/papers/83651 | PubMed |
| 3 | 91516 | Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells. | Eur J Immunol | 1979 | https://conductscience.org/library/papers/91516 | PubMed |
| 4 | 6986204 | Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. | Cell Immunol | 1980 | https://conductscience.org/library/papers/6986204 | PubMed |
| 5 | 7368279 | HLA-DR typing by radioimmunoassay. | Transplantation | 1980 | https://conductscience.org/library/papers/7368279 | PubMed |
| 6 | 6155328 | Purification and separation of subsets of human Ia molecules by papain digestion. | Immunology | 1980 | https://conductscience.org/library/papers/6155328 | PubMed |
| 7 | 6160587 | Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6160587 | PubMed |
| 8 | 6163553 | Effect of type I and type II interferons on murine thymocyte surface antigen expression: induction or selection? | Cell Immunol | 1981 | https://conductscience.org/library/papers/6163553 | PubMed |
| 9 | 6165282 | Interactions of interferon with in vitro model systems involved in hematopoietic cell differentiation. | Ann N Y Acad Sci | 1980 | https://conductscience.org/library/papers/6165282 | PubMed |
| 10 | 6170651 | The preparation of antibodies directed against human immune interferon. | J Virol Methods | 1981 | https://conductscience.org/library/papers/6170651 | PubMed |
| 11 | 6173362 | Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificities. | Hum Immunol | 1981 | https://conductscience.org/library/papers/6173362 | PubMed |
| 12 | 6174218 | Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. | Cancer Res | 1982 | https://conductscience.org/library/papers/6174218 | PubMed |
| 13 | 6957025 | Assessment of the specificity of human Ia alloantisera and alloantigens by the use of radioiodinated human Ia antigens. | Tissue Antigens | 1982 | https://conductscience.org/library/papers/6957025 | PubMed |
| 14 | 6182090 | The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities. | Immunol Rev | 1982 | https://conductscience.org/library/papers/6182090 | PubMed |
| 15 | 6215331 | Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. | Immunol Rev | 1982 | https://conductscience.org/library/papers/6215331 | PubMed |
| 16 | 6982307 | A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity. | J Exp Med | 1982 | https://conductscience.org/library/papers/6982307 | PubMed |
| 17 | 6290893 | Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. | Nature | 1982 | https://conductscience.org/library/papers/6290893 | PubMed |
| 18 | 6752724 | Direct evidence of homology between human DC-1 antigen and murine I-A molecules. | Nature | 1982 | https://conductscience.org/library/papers/6752724 | PubMed |
| 19 | 6401317 | Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line. | J Exp Med | 1983 | https://conductscience.org/library/papers/6401317 | PubMed |
| 20 | 6184829 | Effect of interferon on erythropoietic differentiation. | Tex Rep Biol Med | 1981 | https://conductscience.org/library/papers/6184829 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24213115 | Cytokines in cancer immunotherapy. | Cancers (Basel) | 2011 | https://conductscience.org/library/papers/24213115 | PubMed |
| 10666279 | Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor. | J Virol | 2000 | https://conductscience.org/library/papers/10666279 | PubMed |
| 10490828 | pRB is required for interferon-gamma-induction of the MHC class II abeta gene. | Oncogene | 1999 | https://conductscience.org/library/papers/10490828 | PubMed |
| 7686123 | Biological basis for the clinical use of interferon. | Gut | 1993 | https://conductscience.org/library/papers/7686123 | PubMed |
| 6439741 | Decreased expression of human class II antigens on monocytes from patients with acquired immune deficiency syndrome. Increased expression with interferon-gamma. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6439741 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6413409
GET https://conductscience.org/api/papers/v1/6413409/references?page=2